| H2AFX |
H2AFX, H2AX: Histone H2A.x |
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
102.000 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
GABRB1 |
GABRB1: Gamma-aminobutyric acid receptor subunit beta-1 precursor |
102.000 |
Evidence |
|
| CARD15 |
NOD2, CARD15, IBD1: Nucleotide-binding oligomerization domain-containing protein |
MYD88 |
|
101.000 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
101.000 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PARD6B |
PARD6B, PAR6B: Partitioning defective 6 homolog beta |
101.000 |
Evidence |
|
| WASPIP |
IPI00552369 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
101.000 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
101.000 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
HCK |
IPI00029769 |
101.000 |
Evidence |
|
| HCK |
IPI00029769 |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
101.000 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
101.000 |
Evidence |
|
| NME1 |
NME1, NDPKA, NM23: Nucleoside diphosphate kinase A |
NME2 |
NME2, NM23B: Nucleoside diphosphate kinase B |
101.000 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
LILRB1 |
IPI00385703 |
101.000 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
101.000 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
101.000 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
101.000 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
101.000 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
101.000 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
101.000 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
INSR |
INSR: Insulin receptor precursor |
101.000 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
101.000 |
Evidence |
O
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
101.000 |
Evidence |
|
| F12 |
F12: Coagulation factor XII precursor |
LCAT |
LCAT: Phosphatidylcholine-sterol acyltransferase precursor |
101.000 |
Evidence |
|
| VAMP2 |
VAMP2, SYB2: Vesicle-associated membrane protein 2 |
SCFD1 |
SCFD1, C14orf163, FKSG23, KIAA0917, STXBP1L2: Sec1 family domain-containing prot |
101.000 |
Evidence |
|
| COPZ1 |
COPZ1, COPZ, CGI-120, HSPC181: Coatomer subunit zeta-1 |
COPG |
|
100.000 |
Evidence |
O
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
100.000 |
Evidence |
O
|
-